Di-methyl-Histone H3.1 (K4) Recombinant Monoclonal Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to Di-methyl-Histone H(K4) Recombinant Monoclonal Antibody

The Di-methyl-Histone H3.1 (K4) Recombinant Monoclonal Antibody is a highly specific research tool designed to detect lysine 4 di-methylation (H3K4me2) on histone H3.1, a post-translational modification critical for chromatin structure, gene regulation, and epigenetic memory. This antibody is engineered to target the H3K4me2 epitope, enabling precise analysis of its role in transcriptional activation, developmental regulation, and disease mechanisms.

Key Features

  • Target: Di-methylated lysine 4 (K4) on histone H3.1

  • Applications: ChIP-seq, Western blot (WB), immunocytochemistry (ICC), immunofluorescence (IF), and intracellular flow cytometry

  • Reactivity: Human, mouse, rat, and other species (varies by product)

  • Type: Recombinant monoclonal antibody

Mechanism and Production

The antibody is generated via recombinant DNA technology, which ensures high specificity and reproducibility. The process involves:

  1. Cloning: Genes encoding the antibody’s heavy and light chains are cloned from immunized organisms or synthetic libraries.

  2. Expression: Host cells (e.g., mammalian or bacterial systems) produce the antibody, which is then purified using affinity chromatography.

  3. Validation: Rigorous testing in applications like ChIP-seq, WB, and ICC confirms target binding and minimal cross-reactivity .

Table 1: Production and Validation Overview

StepDetails
ImmunogenSynthetic peptide derived from human H3K4me2
ClonalityMonoclonal (single epitope recognition)
PurificationAffinity chromatography to remove non-specific binding
ValidationTested in ChIP-seq, WB, ICC, IF, and flow cytometry

Applications and Optimization

The antibody is optimized for diverse experimental workflows:

Table 2: Recommended Dilutions by Application

ApplicationDilution RangeSource
Western Blot (WB)1:500–1:2000
ICC/IF1:50–1:500
ChIP-seq2–5 µg per 25–30 µg chromatin
Flow Cytometry1:150–1:500

Key Notes:

  • ChIP-seq: Effective for mapping H3K4me2-enriched regions in promoters and enhancers .

  • ICC/IF: Reveals nuclear localization patterns, with heterogeneity observed in single cells due to dynamic chromatin states .

  • WB: Detects a band at ~15–17 kDa, consistent with histone H3.1 size .

Table 3: Antibody Comparison

ProductHostClonalityApplicationsSpecies ReactivityCitations
ab32356 (Abcam)RabbitMonoclonalChIP-seq, WB, ICC, IFHuman, mouse, rat201
CSB-RA010418A04me2HURabbitMonoclonalWB, ICC, IFHuman, mouseN/A
M12477-22 (Boster)RabbitMonoclonalWB, IHC, ICC, IFHuman, mouse, ratN/A
ab7766 (Abcam)RabbitPolyclonalChIP, WB, ICCHuman, mouse, rat320

Advantages of Recombinant Monoclonals:

  • Specificity: Minimal cross-reactivity to other histone modifications (e.g., H3K9me3) .

  • Consistency: Recombinant production reduces lot-to-lot variability .

  • Sensitivity: Detects low-abundance H3K4me2 marks in complex samples .

Epigenetic Regulation

H3K4me2 is linked to transcriptional activation and chromatin accessibility. Studies using ab32356 have shown:

  • ChIP-seq Data: Enrichment at promoters of actively transcribed genes in HeLa cells .

  • Disease Implications: Altered H3K4me2 patterns in cancer (e.g., cervical carcinoma) correlate with gene dysregulation .

Dynamic Chromatin Behavior

IF studies reveal heterogeneity in H3K4me2 staining across cells, reflecting context-dependent chromatin states .

Methodological Validation

  • CUT&RUN: Demonstrated high-resolution mapping of H3K4me2 in HeLa cells .

  • Flow Cytometry: Quantifies intracellular H3K4me2 levels, useful for studying epigenetic drug responses .

Critical Considerations

  • Cross-Reactivity: Some antibodies (e.g., ab32356) show weak binding to non-K4 histone modifications .

  • Sample Preparation: Formaldehyde fixation (10 mins, 1% v/v) is optimal for ChIP and ICC .

  • Controls: Use isotype-matched IgG (e.g., ab172730) to confirm specificity .

Product Specs

Buffer
Rabbit IgG in phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Description

The production of the di-methyl-Histone H3.1 (K4) recombinant monoclonal antibody is a meticulously crafted process. It begins with the cloning of genes encoding the HIST1H3A antibody, encompassing both heavy and light chains. These cloned genes are then integrated into expression vectors, which are subsequently introduced into host cells through transfection. The host cells are then tasked with producing and secreting the antibody. To ensure its purity and efficacy, the antibody undergoes a rigorous purification process utilizing affinity chromatography. After purification, the antibody is subjected to comprehensive functionality testing across a range of applications, including ELISA, WB, ICC, and IF, making it a versatile tool for accurately detecting the human and mouse HIST1H3A proteins di-methylated at K4.

Di-methylation of Histone H3.1 at lysine 4 (K4) plays a pivotal role in various cellular processes, including transcriptional activation, chromatin accessibility, developmental regulation, epigenetic memory, coordinated gene regulation, and has implications in diverse disease states.

Form
Liquid
Lead Time
Generally, we are able to dispatch products within 1-3 working days after receiving your order. Delivery time may vary depending on the mode of purchase or location. For specific delivery details, kindly consult your local distributors.
Synonyms
H3 histone family member E pseudogene antibody; H3 histone family; member A antibody; H3/A antibody; H31_HUMAN antibody; H3F3 antibody; H3FA antibody; Hist1h3a antibody; HIST1H3B antibody; HIST1H3C antibody; HIST1H3D antibody; HIST1H3E antibody; HIST1H3F antibody; HIST1H3G antibody; HIST1H3H antibody; HIST1H3I antibody; HIST1H3J antibody; HIST3H3 antibody; histone 1; H3a antibody; Histone cluster 1; H3a antibody; Histone H3 3 pseudogene antibody; Histone H3.1 antibody; Histone H3/a antibody; Histone H3/b antibody; Histone H3/c antibody; Histone H3/d antibody; Histone H3/f antibody; Histone H3/h antibody; Histone H3/i antibody; Histone H3/j antibody; Histone H3/k antibody; Histone H3/l antibody
Target Names
Uniprot No.

Target Background

Function

Histone H3.1 is a core component of nucleosomes. Nucleosomes serve to wrap and compact DNA into chromatin, thereby limiting DNA accessibility to cellular machineries that rely on DNA as a template. Consequently, histones play a central role in the regulation of transcription, DNA repair, DNA replication, and chromosomal stability. DNA accessibility is regulated by a complex set of post-translational modifications of histones, often referred to as the histone code, alongside nucleosome remodeling.

Gene References Into Functions
  1. Research suggests that epigenetic regulation in cancer is mediated by the induction of E3 ubiquitin ligase NEDD4-dependent histone H3 ubiquitination. PMID: 28300060
  2. The detection of increased expression of H3K27me3 during a patient's clinical course can be beneficial in determining whether tumors are heterochronous. PMID: 29482987
  3. Studies have shown that JMJD5, a Jumonji C (JmjC) domain-containing protein, acts as a Cathepsin L-type protease that mediates histone H3 N-tail proteolytic cleavage under stress conditions that induce a DNA damage response. PMID: 28982940
  4. Data indicates that the Ki-67 antigen proliferative index exhibits significant limitations, and phosphohistone H3 (PHH3) emerges as an alternative proliferative marker. PMID: 29040195
  5. Research findings demonstrate that cytokine-induced histone 3 lysine 27 trimethylation serves as a mechanism that stabilizes gene silencing in macrophages. PMID: 27653678
  6. This data suggests that, in the early developing human brain, HIST1H3B constitutes the largest proportion of H3.1 transcripts among H3.1 isoforms. PMID: 27251074
  7. In a series of 47 diffuse midline gliomas, the histone H3-K27M mutation was found to be mutually exclusive with IDH1-R132H mutation and EGFR amplification. It rarely co-occurred with BRAF-V600E mutation and was frequently associated with p53 overexpression, ATRX loss, and monosomy 10. PMID: 26517431
  8. Studies demonstrate that histone chaperone HIRA co-localizes with viral genomes, binds to incoming viral, and deposits histone H3.3 onto these. PMID: 28981850
  9. Experiments have shown that PHF13 binds specifically to DNA and to two types of histone H3 methyl tags (lysine 4-tri-methyl or lysine 4-di-methyl), where it functions as a transcriptional co-regulator. PMID: 27223324
  10. Hemi-methylated CpGs DNA recognition activates UHRF1 ubiquitylation towards multiple lysines on the H3 tail adjacent to the UHRF1 histone-binding site. PMID: 27595565
  11. This study provides the first description of the MR imaging features of pediatric diffuse midline gliomas with histone H3 K27M mutation. PMID: 28183840
  12. Approximately 30% of pediatric high-grade gliomas (pedHGG), including GBM and DIPG, harbor a lysine 27 mutation (K27M) in histone 3.3 (H3.3). This mutation is correlated with poor outcome and has been shown to influence EZH2 function. PMID: 27135271
  13. H3F3A K27M mutation in adult cerebellar HGG is not uncommon. PMID: 28547652
  14. Research indicates that lysyl oxidase-like 2 (LOXL2) is a histone modifier enzyme that removes trimethylated lysine 4 (K4) in histone H3 (H3K4me3) through an amino-oxidase reaction. PMID: 27735137
  15. Histone H3 lysine 9 (H3K9) acetylation was most prevalent when the Dbf4 transcription level was highest, while the H3K9me3 level was greatest during and just after replication. PMID: 27341472
  16. The SPOP-containing complex regulates SETD2 stability and H3K36me3-coupled alternative splicing. PMID: 27614073
  17. Data suggests that binding of the helical tail of histone 3 (H3) with PHD ('plant homeodomain') fingers of BAZ2A or BAZ2B (bromodomain adjacent to zinc finger domain 2A or 2B) requires molecular recognition of secondary structure motifs within the H3 tail and could represent an additional layer of regulation in epigenetic processes. PMID: 28341809
  18. Results demonstrate a novel mechanism by which Kdm4d regulates DNA replication by reducing the H3K9me3 level to facilitate the formation of the preinitiation complex. PMID: 27679476
  19. Histone H3 modifications caused by traffic-derived airborne particulate matter exposures in leukocytes have been observed. PMID: 27918982
  20. A key role of persistent histone H3 serine 10 or serine 28 phosphorylation in chemical carcinogenesis through regulating gene transcription of DNA damage response genes has been established. PMID: 27996159
  21. hTERT promoter mutations are frequent in medulloblastoma and are associated with older patients, prone to recurrence and located in the right cerebellar hemisphere. Conversely, histone 3 mutations do not appear to be present in medulloblastoma. PMID: 27694758
  22. AS1eRNA-driven DNA looping and activating histone modifications promote the expression of DHRS4-AS1 to economically control the DHRS4 gene cluster. PMID: 26864944
  23. Data suggests that nuclear antigen Sp100C is a multifaceted histone H3 methylation and phosphorylation sensor. PMID: 27129259
  24. The authors propose that histone H3 threonine 118 phosphorylation via Aurora-A alters the chromatin structure during specific phases of mitosis to promote timely condensin I and cohesin disassociation, which is essential for effective chromosome segregation. PMID: 26878753
  25. Hemi-methylated DNA opens a closed conformation of UHRF1 to facilitate its H3 histone recognition. PMID: 27045799
  26. The functional importance of H3K9me3 in hypoxia, apoptosis, and repression of APAK has been established. PMID: 25961932
  27. Taken together, the authors have verified that histone H3 is a true substrate for GzmA in vivo in Raji cells treated with staurosporin. PMID: 26032366
  28. Research shows that circulating H3 levels correlate with mortality in sepsis patients and inversely correlate with antithrombin levels and platelet counts. PMID: 26232351
  29. Data indicate that double mutations on the residues in the interface (L325A/D328A) decrease the histone H3 H3K4me2/3 demethylation activity of lysine (K)-specific demethylase 5B (KDM5B). PMID: 24952722
  30. Studies indicate that minichromosome maintenance protein 2 (MCM2) binding is not required for the incorporation of histone H3.1-H4 into chromatin but is important for the stability of H3.1-H4. PMID: 26167883
  31. Data suggests that histone H3 lysine methylation (H3K4me3) plays a critical mechanistic role in leukemia stem cell (LSC) maintenance. PMID: 26190263
  32. PIP5K1A modulates ribosomal RNA gene silencing through its interaction with histone H3 lysine 9 trimethylation and heterochromatin protein HP1-alpha. PMID: 26157143
  33. Data indicates that lower-resolution mass spectrometry instruments can be utilized for histone post-translational modifications (PTMs) analysis. PMID: 25325711
  34. Research indicates that inhibition of lysine-specific demethylase 1 activity prevented IL-1beta-induced histone H3 lysine 9 (H3K9) demethylation at the microsomal prostaglandin E synthase 1 (mPGES-1) promoter. PMID: 24886859
  35. The authors report that de novo CENP-A assembly and kinetochore formation on human centromeric alphoid DNA arrays are regulated by a histone H3K9 acetyl/methyl balance. PMID: 22473132
Database Links

HGNC: 4766

OMIM: 137800

KEGG: hsa:8350

STRING: 9606.ENSP00000444823

UniGene: Hs.132854

Involvement In Disease
Glioma (GLM)
Protein Families
Histone H3 family
Subcellular Location
Nucleus. Chromosome.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.